Retro Bio’s Autophagy Drug Enters Phase‑1 – Promising or Overhyped?
Posted by greg208 in Longevity & Anti-Aging - 1 points, 0 comments.
Retro Bio has announced that its autophagy‑enhancing candidate is stepping into a first‑in‑human Phase 1 trial, targeting Alzheimer’s as a potential first indication. The company claims the drug boosts the body’s natural clean‑up processes, which could slow age‑related cellular decline.
I’m cautiously optimistic. The science behind autophagy is solid, and there’s a lot of momentum in the field. But early trials rarely translate into real‑world benefit, and safety profiles can be hit‑hard, especially when you’re pushing systemic cellular pathways. The article glosses over cost, dosing logistics, and the long road to regulatory approval. In my own protocol, I’ve seen modest benefits from lifestyle‑induced autophagy (fasting, cold showers) but no pharmaceutical yet.
Will Retro Bio’s compound actually improve cognitive function in people, or will it just add another expensive pill to the anti‑aging marketplace? What are the risks of long‑term autophagy over‑activation?
Community discussion - research and educational context only. Not medical advice.